keyword
https://read.qxmd.com/read/38634962/en-bloc-inferior-vena-cava-ivc-resection-without-reconstruction-with-right-hepatectomy-and-right-nephrectomy-for-a-large-ivc-leiomyosarcoma
#1
JOURNAL ARTICLE
Gurudutt P Varty, Shraddha Patkar, Kunal Nandy, Mahesh Goel
BACKGROUND: Radical resection remains the only potential cure in the management of inferior vena cava (IVC) leiomyosarcomas with multivisceral resections often needed (Borghi et al. in J Cardiovasc Surg (Torino) 63:649-663, 2022). This video describes the technical nuances of surgical resection of a large retrohepatic IVC leiomyosarcoma. PATIENT AND METHODS: Computed tomography of a 60-year-old woman revealed a 12 × 12 × 9.5 cm mass in the right suprarenal region infiltrating the IVC with intraluminal extension up to the hepatic venous confluence...
April 18, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38634194/long-noncoding-rna-small-nucleolar-rna-host-genes-as-prognostic-molecular-biomarkers-in-hepatocellular-carcinoma-a-meta-analysis
#2
REVIEW
Meng Huang, Zhiwen Zhao, Lihua Yang
BACKGROUND: Recently, increasing data have suggested that the lncRNA small nucleolar RNA host genes (SNHGs) were aberrantly expressed in hepatocellular carcinoma (HCC), but the association between the prognosis of HCC and their expression remained unclear. The purpose of this meta-analysis was to determine the prognostic significance of lncRNA SNHGs in HCC. METHODS: We systematically searched Embase, Web of Science, PubMed, and Cochrane Library for eligible articles published up to February 2024...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38634139/the-role-of-micrornas-in-hepatocellular-cancer-a-narrative-review-focused-on-tumor-microenvironment-and-drug-resistance
#3
REVIEW
Ali Tavakoli Pirzaman, Ali Alishah, Bahareh Babajani, Pouyan Ebrahimi, Seyyed Ali Sheikhi, Farhad Moosaei, Amirhossein Salarfar, Shahrbanoo Doostmohamadian, Sohrab Kazemi
Globally, hepatic cancer ranks fourth in terms of cancer-related mortality and is the sixth most frequent kind of cancer. Around 80% of liver cancers are hepatocellular carcinomas (HCC), which are the leading cause of cancer death. It is well known that HCC may develop resistance to the available chemotherapy treatments very fast. One of the biggest obstacles in providing cancer patients with appropriate care is drug resistance. According to reports, more than 90% of cancer-specific fatalities are caused by treatment resistance...
2024: Technology in Cancer Research & Treatment
https://read.qxmd.com/read/38633673/pembrolizumab-with-bevacizumab-and-cyclophosphamide-for-the-treatment-of-recurrent-ovarian-clear-cell-carcinoma-a-case-series
#4
Shannon M Glynn, Stephanie Gaillard, Rebecca L Stone, Amanda N Fader, Anna L Beavis
INTRODUCTION: Treatment for recurrent ovarian clear cell carcinoma (OCCC) is clinically challenging as response rates to traditional chemotherapy are low, and recurrence rates are high. Immunotherapy has shown promise for this ovarian cancer (OC) subtype, and tumor molecular testing allows for the identification of a patient population that might benefit most from this treatment. We describe the clinical course and somatic genomic testing of 4 patients who received pembrolizumab for recurrent OCCC concurrent with a combination of bevacizumab and/or cyclophosphamide...
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38632219/robotic-biliary-stricturoplasty-and-roux-en-y-hepaticojejunostomy-after-hepatic-artery-infusion-pump-injury
#5
JOURNAL ARTICLE
Emanuel Shapera, Sharona Ross, Tara Pattilachan, Maria Christodoulou, Iswanto Sucandy
BACKGROUND: Hepatic artery infusion pump (HAIP) with floxuridine/dexamethasone and systemic chemotherapy is an established treatment regimen, which had been reported about converting 47% of patients with stage 4 colorectal liver metastasis from unresectable to resectable.1,2 To this effect, HAIP chemotherapy contributes to prolonged survival of many patients, which otherwise may not have other treatment options. Biliary sclerosis, however, is a known complication of the HAIP treatment, which occurs in approximately 5...
April 17, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38631259/a-novel-epigenetic-strategy-to-concurrently-block-immune-checkpoints-pd-1-pd-l1-and-cd155-tigit-in-hepatocellular-carcinoma
#6
JOURNAL ARTICLE
Reem A Assal, Noha M Elemam, Radwa Y Mekky, Abdelrahman A Attia, Aya Hesham Soliman, Asmaa Ibrahim Gomaa, Eleni K Efthimiadou, Maria Braoudaki, Sherif Ashraf Fahmy, Rana A Youness
Tumor microenvironment is an intricate web of stromal and immune cells creating an immune suppressive cordon around the tumor. In hepatocellular carcinoma (HCC), Tumor microenvironment is a formidable barrier towards novel immune therapeutic approaches recently evading the oncology field. In this study, the main aim was to identify the intricate immune evasion tactics mediated by HCC cells and to study the epigenetic modulation of the immune checkpoints; Programmed death-1 (PD-1)/ Programmed death-Ligand 1 (PD-L1) and T cell immunoreceptor with Ig and ITIM domains (TIGIT)/Cluster of Differentiation 155 (CD155) at the tumor-immune synapse...
April 16, 2024: Translational Oncology
https://read.qxmd.com/read/38630548/monitoring-hepatocellular-carcinoma-using-tumor-content-in-circulating-cell-free-dna
#7
JOURNAL ARTICLE
Shifeng Lian, Chenyu Lu, Fugui Li, Xia Yu, Limei Ai, Biao-Hua Wu, Xueyi Gong, Wenjing Zhou, Xuejun Liang, Jiyun Zhan, Yong Yuan, Fang Fang, Zhiwei Liu, Mingfang Ji, Zongli Zheng
PURPOSE: To evaluate the utility of tumor content in circulating cell-free DNA (ccfDNA) for monitoring hepatocellular carcinoma (HCC) throughout its natural history. METHODS: We included 67 hepatitis B virus (HBV)-related HCC patients, of whom 17 had paired pre- and post-treatment samples, and 90 controls. Additionally, in a prospective cohort with HBV surface antigen-positive participants recruited in 2012 and followed up biannually with blood sample collections until 2019, we included 270 repeated samples before diagnosis from 63 participants who later developed HCC (pre-HCC samples)...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38630086/association-between-mr-elastography-liver-stiffness-and-histologic-liver-fibrosis-in-children-and-young-adults-with-autoimmune-liver-disease
#8
JOURNAL ARTICLE
Jonathan R Dillman, Andrew T Trout, Amy E Taylor, Leticia Khendek, Jennifer L Kasten, Rachel Sheridan, Divya Sharma, Rebekah Karns, Cyd Castro Rojas, Bin Zhang, Alexander G Miethke
Background: Liver fibrosis is an important clinical endpoint of progression of autoimmune liver disease (AILD); its monitoring would benefit from noninvasive imaging tools. Objective: To assess the relationship between MR elastography (MRE) liver stiffness measurements and histologic liver fibrosis, as well as to evaluate the performance of MRE and biochemical-based clinical markers for stratifying histologic liver fibrosis severity, in children and young adults with AILD. Methods: This retrospective study used an existing institutional registry of children and young adults diagnosed with AILD [primary sclerosing cholangitis (PSC), ASC (autoimmune sclerosing cholangitis), or AIH (autoimmune hepatitis)]...
April 17, 2024: AJR. American Journal of Roentgenology
https://read.qxmd.com/read/38627684/haic-combined-with-lenvatinib-plus-pd-1-versus-lenvatinib-plus-pd-1-in-patients-with-high-risk-advanced-hcc-a-real-world-study
#9
JOURNAL ARTICLE
Xu Chang, Xinge Li, Peng Sun, Zhenfeng Li, Pengfei Sun, Shangkun Ning
BACKGROUND: The treatment of hepatocellular carcinoma (HCC) patients exhibiting high-risk characteristics (Vp4, and/or bile duct invasion, and/or tumor occupancy ≥ 50%) lacks standardized approaches and yields unfavorable results. This study endeavors to evaluate the safety, efficacy, and prognostic impacts of employing hepatic arterial infusion chemotherapy (HAIC), lenvatinib, and humanized programmed death receptor-1 (PD-1) in the treatment of high-risk HCC patients...
April 16, 2024: BMC Cancer
https://read.qxmd.com/read/38625672/liver-cancer-wars-plant-derived-polyphenols-strike-back
#10
REVIEW
Chengu Niu, Jing Zhang, Patrick I Okolo
Liver cancer currently represents the leading cause of cancer-related death worldwide. The majority of liver cancer arises in the context of chronic inflammation and cirrhosis. Surgery, radiation therapy, and chemotherapy have been the guideline-recommended treatment options for decades. Despite enormous advances in the field of liver cancer therapy, an effective cure is yet to be found. Plant-derived polyphenols constitute a large family of phytochemicals, with pleiotropic effects and little toxicity. They can drive cellular events and modify multiple signaling pathways which involves initiation, progression and metastasis of liver cancer and play an important role in contributing to anti-liver cancer drug development...
April 16, 2024: Medical Oncology
https://read.qxmd.com/read/38623490/trends-in-mortality-from-gastrointestinal-hepatic-and-pancreatic-cancers-in-the-united-states-a-comprehensive-analysis-1999-2020
#11
JOURNAL ARTICLE
Hassam Ali, Rizwan Ishtiaq, Brandon Tedder, Joshua Zweigle, Romina Nomigolzar, Dushyant S Dahiya, Vishali Moond, Amir Humza Sohail, Pratik Patel, Debargha Basuli, Hans L Tillmann
BACKGROUND AND AIM: This study investigates temporal trends in gastrointestinal cancer-related mortality in the United States between 1999 and 2020, focusing on differences by sex, age, and race. METHODS: We investigated the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research multiple causes of death database (Years 1999-2020) for gastrointestinal cancer-related mortality with a focus on the underlying cause of death. RESULTS: A total of 3 115 243 gastrointestinal cancer-related deaths occurred from 1999 to 2020...
April 2024: JGH Open: An Open Access Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38622578/impact-of-hepatic-inflammation-and-fibrosis-on-the-recurrence-and-long-term-survival-of-hepatitis-b-virus-related-hepatocellular-carcinoma-patients-after-hepatectomy
#12
JOURNAL ARTICLE
Xiangyong Hao, Liangliang Xu, Xiang Lan, Bo Li, Hui Cai
BACKGROUND: Underlying liver disease is correlated with hepatocellular carcinoma (HCC) development in patients with hepatitis B virus (HBV) infection. However, the impact of hepatic inflammation and fibrosis on the patients' prognoses remains unclear. METHODS: The clinicopathological data of 638 HBV-infected patients with early-stage HCC between 2017 and 2019 were prospectively collected. Hepatic inflammation and fibrosis were evaluated by experienced pathologists using the Scheuer score system...
April 15, 2024: BMC Cancer
https://read.qxmd.com/read/38620003/18f-fdg-pet-ct-of-intracholecystic-papillary-neoplasm-in-cystic-neck-and-duct
#13
JOURNAL ARTICLE
Jun-Yu Xu, Yong-Kang Shuai, Yan-Ping Xie, Su-E Cao, Qiong Zou
We report 18F-FDG PET/CT appearances of intracholecystic papillary neoplasm (ICPN) in the gallbladder neck and duct of a 74-year-old woman with a history of hepatitis B cirrhosis. The lesion presented with a large and sessile soft mass in the neck and duct of gallbladder with obvious glucose metabolism on PET/CT images, which was confirmed pathologically as ICPN (gastric foveolar type) with high-grade intraepithelial neoplasia. ICPN localized in the gallbladder neck and duct is extremely rare, and is easily misdiagnosed as gallbladder carcinoma...
April 12, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38617864/primary-invasive-ductal-carcinoma-arising-in-axillary-accessory-breast-a-case-report
#14
Seo Young Park, Jeeyeon Lee, Ji Young Park, Gab Chul Kim, Jongmin Park, Jung Geun Cha, Hye Jung Kim
Ectopic breast tissue can develop along the mammary ridge from the axilla to the groin, and the most common site is the axillae. Primary carcinoma of ectopic breast tissue is extremely rare. We report a rare case of a 61-year-old woman with a palpable mass in her left axilla who had a history of surgical excision of accessory breast tissue in the same area. Mammography (MMG), including axillary tail view, ultrasound (US), and breast MRI were performed. We evaluated the extent and characteristics of the microcalcifications in the axillary tail view...
March 2024: J Korean Soc Radiol
https://read.qxmd.com/read/38617024/real-world-study-of-hepatic-artery-infusion-chemotherapy-combined-with-anti-pd-1-immunotherapy-for-hepatocellular-carcinoma-patients-with-portal-vein-tumor-thrombus
#15
JOURNAL ARTICLE
Jinghuan Li, Bing Quan, Wenfeng Liu, Menglong Zhao, Fan Yao, Rongxin Chen, Zhenggang Ren, Xin Yin
BACKGROUND: Patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) present a poor prognosis. Current systemic therapies offer limited benefits. Hepatic artery infusion chemotherapy (HAIC) is a local regional treatment for advanced HCC, particularly in selected patients such as patients with PVTT or high intrahepatic tumor burden. OBJECTIVES: The purpose of this study is to retrospectively evaluate the efficacy and safety of HAIC combined with anti-PD-1 immunotherapy for HCC patients with PVTT, and explore factors related to survival prognosis, providing clues for treatment decisions for HCC patients...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38616850/global-trends-in-hepatitis-c-related-hepatocellular-carcinoma-mortality-a-public-database-analysis-1999-2019
#16
JOURNAL ARTICLE
Hassam Ali, Fnu Vikash, Vishali Moond, Fatima Khalid, Abdur Rehman Jamil, Dushyant Singh Dahiya, Amir Humza Sohail, Manesh Kumar Gangwani, Pratik Patel, Sanjaya K Satapathy
BACKGROUND: Hepatitis C is the leading cause of chronic liver disease worldwide and it significantly contributes to the burden of hepatocellular carcinoma (HCC). However, there are marked variations in the incidence and mortality rates of HCC across different geographical regions. With the advent of new widely available treatment modalities, such as direct-acting antivirals, it is becoming increasingly imperative to understand the temporal and geographical trends in HCC mortality associated with Hepatitis C...
March 25, 2024: World Journal of Virology
https://read.qxmd.com/read/38616543/inter-reader-agreement-for-ct-mri-li-rads-category-m-imaging-features-a-systematic-review-and-meta-analysis
#17
JOURNAL ARTICLE
Dong Hwan Kim, Sang Hyun Choi
BACKGROUNDS/AIMS: To systematically evaluate inter-reader agreement in the assessment of individual Liver Imaging Reporting and Data System (LI-RADS) category M (LR-M) imaging features in computed tomography/magnetic resonance imaging (CT/MRI) LI-RADS v2018, and to explore the causes of poor agreement in LR-M assignment. METHODS: Original studies reporting inter-reader agreement for LR-M features on multiphasic CT or MRI were identified using the MEDLINE, EMBASE, and Cochrane databases...
April 15, 2024: Journal of liver cancer
https://read.qxmd.com/read/38613843/utility-of-clinical-and-mr-imaging-parameters-for-prediction-and-monitoring-of-response-to-capecitabine-and-temozolomide-captem-therapy-in-patients-with-liver-metastases-of-neuroendocrine-tumors
#18
JOURNAL ARTICLE
Maria Ingenerf, Christoph Auernhammer, Roberto Lorbeer, Michael Winkelmann, Shiwa Mansournia, Nabeel Mansour, Nina Hesse, Kathrin Heinrich, Jens Ricke, Frank Berger, Christine Schmid-Tannwald
BACKGROUND: This study explores the predictive and monitoring capabilities of clinical and multiparametric MR parameters in assessing capecitabine and temozolomide (CAPTEM) therapy response in patients with neuroendocrine tumors (NET). PATIENTS AND METHODS: This retrospective study (n = 44) assessed CAPTEM therapy response in neuroendocrine liver metastases (NELM) patients. Among 33 monitored patients, as a subgroup of the overall study cohort, pretherapeutic and follow-up MRI data (size, apparent diffusion coefficient [ADC] values, and signal intensities), along with clinical parameters (chromogranin A [CgA] and Ki-67%), were analyzed...
April 14, 2024: Radiology and Oncology
https://read.qxmd.com/read/38611104/prognostic-indicators-of-overall-survival-in-hepatocellular-carcinoma-patients-undergoing-liver-resection
#19
JOURNAL ARTICLE
Cristina-Paula Ursu, Andra Ciocan, Ștefan Ursu, Răzvan Alexandru Ciocan, Claudia Diana Gherman, Ariana-Anamaria Cordoș, Dan Vălean, Rodica Sorina Pop, Luminița Elena Furcea, Bogdan Procopeț, Horia Ștefănescu, Emil Ioan Moiș, Nadim Al Hajjar, Florin Graur
Hepatocellular carcinoma (HCC) is the predominant form of primary liver cancer and the third contributor to malignancy-related deaths worldwide. The hepatic venous pressure gradient (HVPG), transient elastography-liver stiffness measurement (TE-LSM), and the association between TBS (tumor burden score), alpha-fetoprotein levels, and the Child-Pugh classification (TAC score) can serve as valuable prognostic indicators for these patients. Therefore, the main objective of our research was to analyze the prognostic value of the HVPG, TE-LSM, TBS, and TAC scores...
April 7, 2024: Cancers
https://read.qxmd.com/read/38611092/real-world-data-and-evidence-in-lung-cancer-a-review-of-recent-developments
#20
REVIEW
Eleni Kokkotou, Maximilian Anagnostakis, Georgios Evangelou, Nikolaos K Syrigos, Ioannis Gkiozos
Conventional cancer clinical trials can be time-consuming and expensive, often yielding results with limited applicability to real-world scenarios and presenting challenges for patient participation. Real-world data (RWD) studies offer a promising solution to address evidence gaps and provide essential information about the effects of cancer treatments in real-world settings. The distinction between RWD and data derived from randomized clinical trials lies in the method of data collection, as RWD by definition are obtained at the point of care...
April 4, 2024: Cancers
keyword
keyword
14138
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.